Skip to main content

Table 1 Baseline characteristics of patients with ISH (n = 626)

From: Effectiveness of indapamide/amlodipine single-pill combination in patients with isolated systolic hypertension: post-hoc analysis of the ARBALET study

Parameter

Value

Men, n (%)

165 (26.4)

Women, n (%)

461 (73.6)

Age, years, mean ± SD

66.1 ± 7.8

55–59 years, n (%)

137 (21.9)

60–69 years, n (%)

281 (44.9)

70–79 years, n (%)

171 (27.3)

≥ 80 years, n (%)

30 (4.8)

Risk factors

 

Current smoker, n (%)

103 (16.5)

Dyslipidemia, n (%)

434 (69.3)

Fasting plasma glucose ≥ 5.6 mmol/L, n (%)

146 (23.3)

Abdominal obesity, n (%)

348 (55.6)

Family history of CVD, n (%)

160 (25.6)

Concomitant diseases and conditions

 

Confirmed LVH, n (%)

455 (72.7)

Proteinuria, n (%)

34 (5.4)

CAD, n (%)

208 (33.2)

Stable angina, n (%)

138 (22.0)

History of myocardial infarction, n (%)

40 (6.4)

History of coronary revascularisation, n (%)

29 (4.6)

History of stroke or TIA, n (%)

23 (3.7)

Peripheral artery disease, n (%)

83 (13.3)

Class I or II CHF, n (%)

276 (44.1)

Type 2 diabetes mellitus, n (%)

72 (11.5)

COPD/asthma, n (%)

37 (5.9)

  1. CAD coronary artery disease, CHF chronic heart failure, CVD cardiovascular disease, COPD chronic obstructive pulmonary disease, LVH left ventricular hypertrophy, ISH isolated systolic hypertension, SD standard deviation, TIA transient ischemic attack